Recursion Pharmaceuticals, Inc. Class A Common Stock
RXRX Real Time Price USDRecent trades of RXRX by members of U.S. Congress
No Congress Trading data for this ticker
Congress Trading Dashboard
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
---|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
---|
Recently reported changes by institutional investors
Quarterly net insider trading by RXRX's directors and management
Government lobbying spending instances
No Corporate Lobbying instances for this ticker
Corporate Lobbying DashboardEstimated quarterly lobbying spending
No Corporate Lobbying data for this ticker
Corporate Lobbying DashboardNew patents grants
-
Patent Title: Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings Oct. 15, 2024
-
Patent Title: Utilizing masked autoencoder generative models to extract microscopy representation autoencoder embeddings Oct. 15, 2024
-
Patent Title: Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy Sep. 03, 2024
-
Patent Title: Utilizing machine learning and digital embedding processes to generate digital maps of biology and user interfaces for evaluating map efficacy Aug. 27, 2024
-
Patent Title: Methods of performing animal research Jul. 02, 2024
-
Patent Title: Preemptible-based scaffold hopping Jun. 18, 2024
-
Patent Title: Systems and methods for high throughput compound library creation Jun. 11, 2024
-
Patent Title: Heterocyclic compounds and related methods Mar. 05, 2024
-
Patent Title: Systems and methods for high throughput compound library creation Oct. 17, 2023
-
Patent Title: Preemptible-based scaffold hopping Jul. 18, 2023
-
Patent Title: Electronic monitor for experimental animals Mar. 28, 2023
-
Patent Title: Preemptible-based scaffold hopping Nov. 15, 2022
-
Patent Title: Device and method of measuring animal urine Jul. 26, 2022
-
Patent Title: Systems and methods for high throughput compound library creation Jul. 19, 2022
-
Patent Title: Techniques for analyzing and detecting executional artifacts in microwell plates Jun. 14, 2022
-
Patent Title: Method of measuring efficacy of treatment for an autoimmune disease in vivarium animals Sep. 07, 2021
-
Patent Title: Animal running wheel Aug. 17, 2021
-
Patent Title: Apparatuses containing an emulsion and methods of manufacture Jun. 15, 2021
-
Patent Title: Experimental animal behavioral research methods and apparatuses Mar. 30, 2021
-
Patent Title: Electronic monitor for experimental animals Feb. 16, 2021
-
Patent Title: Ordered picklist for liquid transfer Aug. 11, 2020
-
Patent Title: Systems and methods for discriminating effects on targets May. 07, 2019
-
Patent Title: Systems and methods for evaluating whether perturbations discriminate an on target effect Dec. 04, 2018
Federal grants, loans, and purchases
No Government Contracts for this ticker
Government Contracts DashboardEstimated quarterly amount awarded from public contracts
Number of mentions of RXRX in WallStreetBets Daily Discussion
Recent insights relating to RXRX
Recent picks made for RXRX stock on CNBC
ETFs with the largest estimated holdings in RXRX
Shareholder
|
Shares Held
|
---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view RXRX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.